FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
This Quarter Return
+11.83%
1 Year Return
+33.53%
3 Year Return
+83.32%
5 Year Return
+196.78%
10 Year Return
+650.37%
AUM
$261M
AUM Growth
+$261M
(+7.8%)
Cap. Flow
+$3.81M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
28.84%
Holding
189
New
7
Increased
51
Reduced
56
Closed
5
Top Buys
| 1 |
Apple
AAPL
|
$1.76M |
| 2 |
Microsoft
MSFT
|
$1.48M |
| 3 |
Walmart
WMT
|
$615K |
| 4 |
BridgeBio Pharma
BBIO
|
$563K |
| 5 |
Accenture
ACN
|
$414K |
Top Sells
| 1 |
Iridium Communications
IRDM
|
$2.17M |
| 2 |
Eli Lilly
LLY
|
$682K |
| 3 |
COUP
Coupa Software Incorporated
COUP
|
$386K |
| 4 |
Biogen
BIIB
|
$348K |
| 5 |
Axon Enterprise
AXON
|
$245K |
Sector Composition
| 1 | Healthcare | 18.18% |
| 2 | Technology | 14.35% |
| 3 | Energy | 8.35% |
| 4 | Consumer Discretionary | 7.7% |
| 5 | Financials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Texas Pacific Land
TPL
$21.5B
| $13.4M | 5.13% | 7,853 +133 | +2% | +$226K |
|
|
2
Apple
AAPL
$3.45T
| $12.4M | 4.74% | 74,918 +10,679 | +17% | +$1.76M |
|
3
iShares Core S&P 500 ETF
IVV
$662B
| $9.15M | 3.51% | 22,265 +426 | +2% | +$175K |
|
4
Pliant Therapeutics
PLRX
$101M
| $8.33M | 3.2% | 313,248 +8,675 | +3% | +$231K |
|
5
Vanguard Mega Cap Growth ETF
MGK
$28.9B
| $6.63M | 2.54% | 32,405 -379 | -1% | -$77.5K |
|
6
MongoDB
MDB
$25.7B
| $5.55M | 2.13% | 23,789 +332 | +1% | +$77.4K |
|
7
iShares US Consumer Staples ETF
IYK
$1.35B
| $5.34M | 2.05% | 26,827 -898 | -3% | -$179K |
|
8
MSCI
MSCI
$43.9B
| $4.92M | 1.89% | 8,798 +78 | +0.9% | +$43.7K |
|
9
Amazon
AMZN
$2.44T
| $4.77M | 1.83% | 46,214 +1,636 | +4% | +$169K |
|
10
iShares Core Dividend Growth ETF
DGRO
$33.7B
| $4.72M | 1.81% | 94,465 +5,140 | +6% | +$257K |
|
11
Alphabet (Google) Class A
GOOGL
$2.57T
| $4.62M | 1.77% | 44,538 +2,553 | +6% | +$265K |
|
12
Ares Capital
ARCC
$15.8B
| $4.62M | 1.77% | 252,580 +9,594 | +4% | +$175K |
|
13
Meta Platforms (Facebook)
META
$1.86T
| $4.61M | 1.77% | 21,732 -75 | -0.3% | -$15.9K |
|
|
14
Eli Lilly
LLY
$657B
| $4.21M | 1.61% | 12,248 -1,985 | -14% | -$682K |
|
15
CVS Health
CVS
$92.8B
| $4.04M | 1.55% | 54,430 +54 | +0.1% | +$4.01K |
|
|
16
BridgeBio Pharma
BBIO
$9.89B
| $3.93M | 1.51% | 236,975 +33,975 | +17% | +$563K |
|
|
17
Microsoft
MSFT
$3.77T
| $3.71M | 1.42% | 12,858 +5,118 | +66% | +$1.48M |
|
18
Visa
V
$683B
| $3.53M | 1.36% | 15,657 +1,778 | +13% | +$401K |
|
19
Johnson & Johnson
JNJ
$427B
| $3.38M | 1.3% | 21,833 +1,608 | +8% | +$249K |
|
20
Relay Therapeutics
RLAY
$619M
| $3.05M | 1.17% | 185,063 | – | – |
|
21
Philip Morris
PM
$260B
| $3.04M | 1.17% | 31,237 -565 | -2% | -$54.9K |
|
22
Union Pacific
UNP
$133B
| $3.02M | 1.16% | 14,983 +15 | +0.1% | +$3.02K |
|
23
Altria Group
MO
$113B
| $2.99M | 1.15% | 67,081 -111 | -0.2% | -$4.95K |
|
|
24
Axon Enterprise
AXON
$58.7B
| $2.84M | 1.09% | 12,650 -1,090 | -8% | -$245K |
|
25
iShares Russell 1000 ETF
IWB
$43.2B
| $2.81M | 1.08% | 12,473 | – | – |
|